Showing 21 - 40 results of 145 for search '"Tumor suppressor gene"', query time: 0.08s Refine Results
  1. 21
  2. 22

    Differences in phenotypes of normal and malignant cells concerning chromosomal fragility and ganglioside expression by Iskra Sainova, Vera Kolyovska, Desislava Drenska, Dimitar Maslarov, Dimitrina Dimitrova-Dikanarova, Tzvetanka Markova

    Published 2025-02-01
    “…Additionally, the presence and expression of the tumor-suppressor gene HACE-1 in the genome of mouse embryonic stem cells (mESCs) and malignant human cervical carcinoma HeLa cells, both containing an additional copy of this gene, inserted by transfection with appropriate recombinant DNA vectors containing a copy of the tumor-suppressor gene, were tested. …”
    Get full text
    Article
  3. 23

    FHIT Doubts are Clear Now by Anjilna Wali

    Published 2010-01-01
    “…The fragile histidine triad (FHIT) gene is a bonafide tumor-suppressor gene present on the short arm of chromosome 3 and its loss of function has been evaluated in different types of cancers. …”
    Get full text
    Article
  4. 24

    Expression of WW Domain-Containing Oxidoreductase WOX1 in Human Nervous System Tumors by Ming-Fu Chiang, Shur-Tzu Chen, Chen-Peng Lo, Chun-I Sze, Nan-Shan Chang, Yu-Jen Chen

    Published 2013-01-01
    “…Background and ObjectiveS: We aimed to evaluate the expression levels of the tumor suppressor WOX1 in nervous system tumors and its co-expression with p53 and neurofibromatosis type 2/merlin (NF2) tumor suppressor gene products.…”
    Get full text
    Article
  5. 25

    Breast Cancer in Teenager with Neurofibromatosis 1 by Nariman Khan, Isadora Linford, Sara Ortiz Romero

    Published 2024-10-01
    “…Review of literature demons trates a five-fold increased risk of developing breast cancer before age 50 with a mutation in this tumor suppressor gene. Incorporation of earlier screening recommenda tions for at-risk younger women is warranted in more guide lines. …”
    Get full text
    Article
  6. 26

    Familial Aggregation of Urinary Tract and Bone Tumors: Searching for a Syndrome by Andreas Frings, Jochen B. Geigl, Bernadette Liegl-Atzwanger, Andreas Leithner

    Published 2012-01-01
    “…To confirm Li-Fraumeni syndrome, we set out to investigate this case by analyzing the tumor suppressor gene p53. However, taking into account all the diagnostic results obtained, Li-Fraumeni syndrome could not be confirmed, but there is still uncertainty regarding a definitive diagnosis.…”
    Get full text
    Article
  7. 27

    Nongenomic Mechanisms of PTEN Regulation by Jimmie E. Fata, Shawon Debnath, Edmund C. Jenkins, Marcia V. Fournier

    Published 2012-01-01
    “…A large amount of data supports the view that PTEN is a bona fide tumor suppressor gene. However, recent evidence suggests that derailment of cellular localization and expression levels of functional nonmutated PTEN is a determining force in inducing abnormal cellular and tissue outcomes. …”
    Get full text
    Article
  8. 28

    胃癌中 MTS1 基因异常甲基化的研究 by 全欣鑫, 周晓东

    Published 2000-01-01
    “…【目的】探讨多肿瘤抑制基因(multiple tumor suppressor gene 1, MTS1)5′端 CpG 岛异常甲基化与原发性胃癌发 病机制之间的关系。…”
    Get full text
    Article
  9. 29

    Annotation of Genes Having Candidate Somatic Mutations in Acute Myeloid Leukemia with Whole-Exome Sequencing Using Concept Lattice Analysis by Kye Hwa Lee, Jae Hyeun Lim, Ju Han Kim

    Published 2013-03-01
    “…In cancer genome studies, the annotation of newly detected oncogene/tumor suppressor gene candidates is a challenging process. …”
    Get full text
    Article
  10. 30

    FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. by Qing Li, Yan Li, Tong Zhou, Yong Zhang, Huiyu Li, Fajia Yuan, Yanghui Bi

    Published 2025-01-01
    “…FBXW7 is a tumor suppressor gene that regulates metabolism and is associated with the onset and progression of colorectal cancer (CRC)), however, the precise mechanism whereby FBXW7 participates in the metabolic reprogramming of CRC remains unclear. …”
    Get full text
    Article
  11. 31

    Genetic Alterations in Presumptive Precursor Lesions of Breast Carcinomas by Michaela Aubele, Martin Werner, Heinz Höfler

    Published 2002-01-01
    “…An expression of mutant p53 tumor suppressor gene as well as expression of cyclin D1 was identified in DCIS. …”
    Get full text
    Article
  12. 32

    Comparison of BRCA1 Gene Expression and CA15-3 Tumor Marker Level in Different Stages of Breast Cancer by Negar Soltani Irdmusa, Haniyeh Bashi Zadeh Fakhar, Masoumeh Heshmati, Mohammad Esmaiel Akbari, Sara Rahimi

    Published 2024-01-01
    “…In this study, we examined the expression of the tumor suppressor gene BRCA1 and the tumor marker CA15-3 in women diagnosed with BC, focusing on different cancer grades. …”
    Get full text
    Article
  13. 33

    MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer by Zhiguang Liu, Xinlian Wang, Liqiang Cao, Xiaowei Yin, Qian Zhang, Lan Wang

    Published 2022-01-01
    “…Many researches revealed that microRNAs (miRNAs) function as potential oncogene or tumor suppressor gene. As an antioncogene, miR-877-5p was reduced in many tumors. …”
    Get full text
    Article
  14. 34

    EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction by Rui Liu, Zongwei Li, Rui Chen, Zhihong Fang, Zhiqiang Liu, Huan Liu

    Published 2025-01-01
    “…This complex promotes trimethylation at lysine 27 of histone H3 (H3K27me3) in the promoter region of the tumor suppressor gene EMP1, resulting in transcriptional silencing. …”
    Get full text
    Article
  15. 35

    INI1 (SMARCB1) deletion of lung cancer: a case report and literature review by Hong-Yan Ma, Shuai Shi, Yin Zhou Sang, Jie Sun, Xing-guang Wang, Zhi-Gang Zhang

    Published 2024-12-01
    “…Abstract Background Integrase interaction factor 1 (INI1), also known as switch/sucrose non-fermentable (SWI/SNF)-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), is a tumor suppressor gene. The INI1 protein is widely expressed in normal cell nuclei. …”
    Get full text
    Article
  16. 36

    Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages by Rui Ma, Ping Yuan, Xiaolin Wang, Yingjie Li, Meijin Huang, Huichuan Yu, Yanxin Luo, Mingxuan Zhu, Liangliang Bai, Xiaoxia Liu, Shaoyong Peng, Yumo Xie, Hong Bai, Jinxin Lin, Linping Wu

    Published 2022-12-01
    “…We utilized a CSF1R inhibitor PLX3397 to ablate M2 TAMs and evaluated its efficacy on CRC treatment in animal models.Results We found here that the CSF1R is silenced in CRC, and the reintroduced expression of the receptor in CRC cells can be cleaved by caspases and constrain tumor growth in vitro and in vivo, functioning as a tumor suppressor gene. We further identified CSF1R as a novel dependence receptor, which has the potential to act as either a tumor suppressor gene or an oncogene, depending on its activated state. …”
    Get full text
    Article
  17. 37

    A Newborn with Cleft Palate Associated with PTEN Hamartoma Tumor Syndrome by Ulf Nestler, Daniel Gräfe, Vincent Strehlow, Robin-Tobias Jauss, Andreas Merkenschlager, Annika Schönfeld, Florian Wilhelmy

    Published 2025-01-01
    “…<b>Background</b>: PTEN hamartoma tumor syndrome (PHTS) has evolved into an umbrella term for a range of syndromes, characterized by loss-of-function variants in the phosphatase and tensin homolog (PTEN) tumor suppressor gene on chromosome 10q23.31. This can result in a lifelong tumor predisposition in patients. …”
    Get full text
    Article
  18. 38

    A Pediatric Case of Cowden Syndrome with Graves’ Disease by Cláudia Patraquim, Vera Fernandes, Sofia Martins, Ana Antunes, Olinda Marques, José Luís Carvalho, Jorge Correia-Pinto, Carla Meireles, Ana Margarida Ferreira

    Published 2017-01-01
    “…In 80% of cases, the human tumor suppressor gene phosphatase and tensin homolog (PTEN) is mutated. …”
    Get full text
    Article
  19. 39

    Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential by Mai O. Kadry, Rehab M. Abdel-Megeed

    Published 2024-12-01
    “…This article summarizes necroptosis progress in reconizing cisplatinum nephrotoxicity and debates how this progress can help in discovering more potent therapy via lactoferrin and Ti-NPS conjugation via monitoring autophagy and apoptotic biomarkers X-box-binding protein 1 (XBP), C/EBP homologous protein (CHOP), hypoxanthine phosphoribosyltransferase-1 (HPRT), FKBP prolyl isomerase 1B (FKBP), Cellular myelocytomatosis oncogene (C-myc), tumor suppressor gene (P53) and tumor necrosis factor (TNF-α). …”
    Get full text
    Article
  20. 40

    What have we learned about TP53-mutated acute myeloid leukemia? by Moazzam Shahzad, Muhammad Kashif Amin, Naval G. Daver, Mithun Vinod Shah, Devendra Hiwase, Daniel A. Arber, Mohamed A. Kharfan-Dabaja, Talha Badar

    Published 2024-11-01
    “…Abstract TP53 is a tumor suppressor gene frequently mutated in human cancers and is generally associated with poor outcomes. …”
    Get full text
    Article